Frequency of variants of unknown significance and DCIS in women <â50Â years of age by gene. (DOCX 19 kb
Breast cancer (BC) patients considered for the study, their age at diagnosis and the number of affec...
PDAVs found in the CAPG of the 120 control samples and their occurrence in the general population. (...
Comparison of the frequency of select mutational events in breast cancer tumours versus cell lines. ...
Age of onset of DCIS and family history details of women with two pathogenic variants in different g...
Pathogenic mutations in BRCA1 (NM_007294.3) and BRCA2 (NM_000059.3) genes (n = 96) detected in 398 p...
The independent association between age at diagnosis and chromosomal copy number variation (CNV) eve...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Ndiaye R BRCA2 Supplementary Material. Table S1 Primers used for BRCA1 coding exons PCR amplificatio...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Deleterious BRCA1/2 germline mutations in Pakistani patients with TNBC. (DOCX 24Â kb
List with PDAVs detected in 54âBC patients located in genes linked to (hereditary) cancer and/or h...
Figure S1. Bioinformatics workflow for detecting pathogenic variants. Variants are first binned into...
This file includes two tables regarding baseline characteristics of study participants, possibly pat...
Breast cancer (BC) patients considered for the study, their age at diagnosis and the number of affec...
PDAVs found in the CAPG of the 120 control samples and their occurrence in the general population. (...
Comparison of the frequency of select mutational events in breast cancer tumours versus cell lines. ...
Age of onset of DCIS and family history details of women with two pathogenic variants in different g...
Pathogenic mutations in BRCA1 (NM_007294.3) and BRCA2 (NM_000059.3) genes (n = 96) detected in 398 p...
The independent association between age at diagnosis and chromosomal copy number variation (CNV) eve...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Ndiaye R BRCA2 Supplementary Material. Table S1 Primers used for BRCA1 coding exons PCR amplificatio...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Deleterious BRCA1/2 germline mutations in Pakistani patients with TNBC. (DOCX 24Â kb
List with PDAVs detected in 54âBC patients located in genes linked to (hereditary) cancer and/or h...
Figure S1. Bioinformatics workflow for detecting pathogenic variants. Variants are first binned into...
This file includes two tables regarding baseline characteristics of study participants, possibly pat...
Breast cancer (BC) patients considered for the study, their age at diagnosis and the number of affec...
PDAVs found in the CAPG of the 120 control samples and their occurrence in the general population. (...
Comparison of the frequency of select mutational events in breast cancer tumours versus cell lines. ...